The International Alliance of Patients’ Organizations, with support from the African Medicines Agency Treaty Alliance (AMATA), commends WHO and Member States for sustained attention to the public health threat posed by substandard and falsified medical products.

Regional regulatory systems have proven life-saving, offering protection, rapid response, and cross-border coordination.

Once operational, the African Medicines Agency will address Africa's specific needs by harmonizing regulations, enhancing oversight across borders, and ensuring no country is left behind fighting substandard and falsified products.

Through our #AfricanMedsAgencyNOW campaign, AMATA urges all African Member States to urgently ratify the Agency Treaty, and calls global partners, including WHO, to support the implementation of the Agency as a strategic partner in this global effort, ensuring patient safety and patients’ timely access to effective and quality-assured medicines across Africa.

Thank you.